In recent months, Tandem Diabetes Care reported strong third-quarter 2025 results that exceeded revenue and earnings expectations, reaffirmed its goal of achieving positive EBITDA for full-year 2025, ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal ...

15 analysts have shared their evaluations of Tandem Diabetes Care (NASDAQ:TNDM) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a ...

Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward ...

Tandem Diabetes Care recently received FDA clearance for its Control-IQ+ automated insulin delivery technology to be used during pregnancies complicated by type 1 diabetes, covering both its t:slim X2 ...

Tandem Diabetes Care (TNDM) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $-0.33 and quarterly revenue of $255.64M. In the most recent quarter (Q1), Tandem Diabetes ...

Shares of Tandem Diabetes Care (NASDAQ: TNDM) climbed 10.9% on Thursday despite weaker-than-expected quarterly results from the diabetes treatment device company. The market appears to be focused on ...

Helping toddlers manage their Type 1 diabetes—typically a difficult task, due to their constant growth and development, not to mention fussiness—may now be a bit easier. The FDA has expanded its ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS) criteria for insulin pump coverage. SAN ...

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and ...

Shares of Tandem Diabetes Care (NASDAQ: TNDM) leaped on Friday after the insulin delivery specialist reported significant gains in profitability. By the close of trading, Tandem's stock price was up ...